美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

Triamcinolone Acetonide 50 mg/mL

HUMAN COMPOUNDED DRUG

69852-691

Eagle Pharma Outsourcing, LLC

2024-2

TRIAMCINOLONE ACETONIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg/50 mg

69852-691-10

Brompheniramine Maleate

HUMAN COMPOUNDED DRUG

69852-881

Eagle Pharma Outsourcing, LLC

2024-2

BROMPHENIRAMINE MALEATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/10 mg

69852-881-10

Methylprednisolone Acetate 40 mg/mL

HUMAN COMPOUNDED DRUG

69852-115

Eagle Pharma Outsourcing, LLC

2024-2

METHYLPREDNISOLONE ACETATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

40 mg/40 mg

69852-115-10

Triamcinolone Acetonide 80 mg/mL

HUMAN COMPOUNDED DRUG

69852-496

Eagle Pharma Outsourcing, LLC

2024-2

TRIAMCINOLONE ACETONIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

80 mg/80 mg

69852-496-10

Betamethasone 7 mg/mL

HUMAN COMPOUNDED DRUG

69852-216

Eagle Pharma Outsourcing, LLC

2024-2

BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

3 mg/7 mg; 4 mg/7 mg

69852-216-10

Dexamethasone Acetate 8 mg/mL

HUMAN COMPOUNDED DRUG

69852-776

Eagle Pharma Outsourcing, LLC

2024-2

DEXAMETHASONE ACETATE ANHYDROUS

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

8 mg/8 mg

69852-776-10

Trophamine 3% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

72196-0405

Central Admixture Pharmacy Services, Inc.

2024-2

GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL

72196-0405-1

Trophamine 3.5%/Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

71285-0429

Central Admixture Pharmacy Services, Inc.

2024-2

HEPARIN SODIUM; CALCIUM GLUCONATE MONOHYDRATE; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

125 U/250 mL; 2.33 meq/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL

71285-0429-1

Trophamine 3.5%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag

HUMAN COMPOUNDED DRUG

71285-0421

Central Admixture Pharmacy Services, Inc.

2024-2

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

125 U/250 mL; 3.75 meq/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL

71285-0421-1

SEMAGLUTIDE

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.5 mg/.1 mL

81483-0046-4

SEMAGLUTIDE

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/.2 mL

81483-0047-4

Diltiazem HCl

HUMAN COMPOUNDED DRUG

63037-119

Hikma Injectables USA Inc.

2024-2

DILTIAZEM HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

125 mg/125 mL

63037-119-05

Lidocaine HCl 2%

HUMAN COMPOUNDED DRUG

63037-164

Hikma Injectables USA Inc.

2024-2

LIDOCAINE HYDROCHLORIDE ANHYDROUS

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 mg/5 mL

63037-164-25

Lidocaine HCl 1%

HUMAN COMPOUNDED DRUG

63037-162

Hikma Injectables USA Inc.

2024-2

LIDOCAINE HYDROCHLORIDE ANHYDROUS

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg/5 mL

63037-162-25

Diltiazem HCl

HUMAN COMPOUNDED DRUG

63037-117

Hikma Injectables USA Inc.

2024-2

DILTIAZEM HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

125 mg/125 mL

63037-117-05

Ephedrine Sulfate

HUMAN COMPOUNDED DRUG

63037-123

Hikma Injectables USA Inc.

2024-2

EPHEDRINE SULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg/5 mL

63037-123-25

Ketamine HCl

HUMAN COMPOUNDED DRUG

63037-136

Hikma Injectables USA Inc.

2024-2

KETAMINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg/5 mL

63037-136-25

TESTOSTERONE 2.5%

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg/1 g

26436-5280-1

LIDOCAINE TETRACAINE 23%/7%

HUMAN COMPOUNDED DRUG

26436-5324

Hybrid Pharma

2024-2

TETRACAINE; LIDOCAINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

70 mg/1 g; 230 mg/1 g

26436-5324-1

POTASSIUM CHLORIDE

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.2 meq/1 mL

26436-6001-1

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：